Literature DB >> 28840466

Advances in Percutaneous Therapies for Peripheral Artery Disease: Drug-Coated Balloons.

Rasha F Al-Bawardy1, Stephen W Waldo2, Kenneth Rosenfield3.   

Abstract

PURPOSE OF REVIEW: This review paper provides a summary on the use of drug-coated balloons in peripheral artery disease. It covers the main drug-coated balloon (DCB) trials. It is divided into categories of lesions: superficial femoral artery and popliteal lesions, infra-popliteal lesions and in-stent restenosis. It also includes an overview of the future of DCBs, highlighting the main ongoing trials. RECENT
FINDINGS: The latest research on DCB focuses on newer types of DCBs, mainly paclitaxel-coated but with lower doses. Another area of latest DCB research is its use in superficial femoral artery and popliteal artery in-stent restenosis, with superior outcomes. Drug-coated balloons produce better outcomes than percutaneous transluminal angioplasty alone in de novo and in-stent restenosis lesions of superficial femoral artery and popliteal arteries. More data are needed to demonstrate efficacy and safety of DCBs in infrapopliteal disease. Newer DCBs and adjunctive therapy may provide improved outcomes for peripheral artery disease interventions.

Entities:  

Keywords:  Drug-coated balloons; In-stent restenosis; Infrapopliteal disease; Peripheral artery disease; Popliteal artery; Superficial femoral artery

Mesh:

Year:  2017        PMID: 28840466     DOI: 10.1007/s11886-017-0913-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  31 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  Influence of stent fracture on the long-term patency in the femoro-popliteal artery: experience of 4 years.

Authors:  Osamu Iida; Shinsuke Nanto; Masaaki Uematsu; Kuniyasu Ikeoka; Shin Okamoto; Seiki Nagata
Journal:  JACC Cardiovasc Interv       Date:  2009-07       Impact factor: 11.195

3.  Balloon coating with rapamycin using an on-site coating device.

Authors:  Jörg Schmehl; Jürgen von der Ruhr; Markus Dobratz; Rainer Kehlbach; Isabelle Braun; Tim-Oliver Greiner; Claus D Claussen; Boris Behnisch
Journal:  Cardiovasc Intervent Radiol       Date:  2013-02-22       Impact factor: 2.740

4.  Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery.

Authors:  Martin Schillinger; Schila Sabeti; Christian Loewe; Petra Dick; Jasmin Amighi; Wolfgang Mlekusch; Oliver Schlager; Manfred Cejna; Johannes Lammer; Erich Minar
Journal:  N Engl J Med       Date:  2006-05-04       Impact factor: 91.245

5.  Angiographic, optical coherence tomography and histology findings from combination of a drug-coated balloon with an everolimus-eluting stent in a porcine model.

Authors:  Paul J L Ong; Takashi Kubo; Timothy J Watson; Agnes S P Seah; Philip E H Wong; Takashi Akasaka
Journal:  Int J Cardiol       Date:  2016-08-18       Impact factor: 4.164

6.  Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial.

Authors:  Fabrizio Fanelli; Alessandro Cannavale; Emanuele Boatta; Mario Corona; Pierleone Lucatelli; Andrea Wlderk; Carlo Cirelli; Filippo Maria Salvatori
Journal:  J Endovasc Ther       Date:  2012-10       Impact factor: 3.487

7.  Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).

Authors:  Hans Krankenberg; Michael Schlüter; Hermann J Steinkamp; Karlheinz Bürgelin; Dierk Scheinert; Karl-Ludwig Schulte; Erich Minar; Patrick Peeters; Marc Bosiers; Gunnar Tepe; Bernhard Reimers; Felix Mahler; Thilo Tübler; Thomas Zeller
Journal:  Circulation       Date:  2007-06-25       Impact factor: 29.690

8.  Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.

Authors:  Thomas Zeller; Iris Baumgartner; Dierk Scheinert; Marianne Brodmann; Marc Bosiers; Antonio Micari; Patrick Peeters; Frank Vermassen; Mario Landini; David B Snead; K Craig Kent; Krishna J Rocha-Singh
Journal:  J Am Coll Cardiol       Date:  2014-10-14       Impact factor: 24.094

9.  Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.

Authors:  Gunnar Tepe; John Laird; Peter Schneider; Marianne Brodmann; Prakash Krishnan; Antonio Micari; Christopher Metzger; Dierk Scheinert; Thomas Zeller; David J Cohen; David B Snead; Beaux Alexander; Mario Landini; Michael R Jaff
Journal:  Circulation       Date:  2014-12-03       Impact factor: 29.690

Review 10.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.